Genome-wide Association Study (GWAS) For Juvenile-onset Myopia And Its Component Measures To Identify Molecular Pathways To Prevent Myopia
Funder
National Health and Medical Research Council
Funding Amount
$495,364.00
Summary
We will examine 2,000 young adults from the Western Australian Raine Cohort at the Lions Eye Institute / University of Western Australia. Ocular data will be collected relating to myopia (short-sightedness) and will be combined with extensive previous childhood and genetic research data collected on the Cohort, to investigate the genetic and environmental factors predisposing to myopia. This will assist in understanding the factors leading to myopia.
Unravelling The Mechanism Of MHC Class-I Associated Drug Hypersensitivities
Funder
National Health and Medical Research Council
Funding Amount
$566,308.00
Summary
Some drugs cause adverse reactions that are life threatening. We think these reactions are mediated by killer T cells as they are genetically controlled by immune response genes that normally guide immunity to microbes. We will study immune reactions to the drug abacavir, used to treat HIV (AIDS); allopurinol used to prevent gout and carbamazepine, used to treat epilepsy. The study may also help devise better treatments for patients who experience severe forms of these reactions.
DYRK1A As A Novel Target For Glioblastoma Therapies
Funder
National Health and Medical Research Council
Funding Amount
$620,294.00
Summary
Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called DYRK1A (using ‘DYRK1A inhibitors’) kills glioblastoma cells. This therapeutic advantage is even greater when combined with drugs approved for other cancers. This project will develop new DYRK1A inhibitors and examine a novel combination treatment for glioblastoma patients. This could initiate a novel therapy that could significantly extend patients’ lives.
Preclinical Development Of A Therapeutic Anticancer Antibody To C-Met
Funder
National Health and Medical Research Council
Funding Amount
$435,530.00
Summary
Many common cancers cannot be effectively treated. A range of these cancers (e.g. gastric and lung cancer) display the molecule c-Met on their cell surface. c-Met promotes tumour growth; therefore, blocking c-Met is a promising strategy for treating these cancers. However, no antibodies or drugs that target c-Met have been licensed. The therapeutics that are being developed to target c-Met all have considerable limitations. Thus, there is an opportunity to develop a 'best-in-class' therapeutic.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100041
Funder
Australian Research Council
Funding Amount
$100,000.00
Summary
A high-resolution isotope facility for low cost analysis of water, plant, and soil/sediment samples to understand environmental change. The most significant environmental challenges facing Australia include ensuring sustainable management of our water resources and conservation of both terrestrial and marine biodiversity, particularly in the face of our changing climate and land-use. The new instruments will accelerate progress across a number of projects aimed at understanding the developme ....A high-resolution isotope facility for low cost analysis of water, plant, and soil/sediment samples to understand environmental change. The most significant environmental challenges facing Australia include ensuring sustainable management of our water resources and conservation of both terrestrial and marine biodiversity, particularly in the face of our changing climate and land-use. The new instruments will accelerate progress across a number of projects aimed at understanding the development of groundwater resources, the relative dependency of ecosystems on groundwater versus soil and surface water, and an assessment of the likely impacts of altered hydrology, especially dewatering and salinisation, on ecosystems. In addition, they will also be used to extend our knowledge of climate variability in the recent past and increase understanding of critical marine resources.Read moreRead less